Risperidone in the treatment of autistic Thai children under 4 years of age

Journal of the Medical Association of Thailand

Volumn 85, Issue SUPPL. 2, 2002, Pages

  Boon Yasidhi, Vitharon ^a   Suwanwattana, Chomyong ^a   Tarugsa, Jariya ^a   Soising, Ladda ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Autistic; Pervasive Developmental Disorders; Risperidone

Indexed keywords

METHYLPHENIDATE; RISPERIDONE;

AGGRESSIVENESS; ARTICLE; AUTISM; CLINICAL ARTICLE; CLINICAL FEATURE; COOPERATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; HUMAN; HYPERACTIVITY; IRRITABILITY; MALE; OCCUPATIONAL THERAPY; PRESCHOOL CHILD; SOCIAL INTERACTION; SPEECH THERAPY; SYMPTOM; THAILAND;

AUTISTIC DISORDER; CHILD, PRESCHOOL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; MALE; RISPERIDONE; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; THAILAND; TREATMENT OUTCOME;

EID: 0036703212     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Tanguay P. Pervasive developmental disorders: A 10-year review. J Am Acad Child Adolesc Psychiatry 2000; 39: 1079-95.
2. McDougle CJ, Lawrence S, McCracken JT, et al. Research Units on Pediatric Psychopharmacology (RUPP)-Autism Network: Background and rationale for an initial controlled study of risperidone. Child Adolesc Psychiatr Clin N Am 2000; 9: 201-24.
3. Cook E. Review of neurochemical investigation. Synapse 1990; 6: 293-308.
4. Anderson L, Campbell M. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Dev Disord 1989; 19: 227-39.
5. Campbell M, Armenteros JL, Malone RP, Adams PB, Eisenberg ZW, Overall JE. Neuroleptic-related dyskinesias in autistic children: A prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry 1997; 36: 835-43.
6. Locascio J, Malone R, Small A, et al. Factors related to haloperidol response and dyskinesias in autistic children. Psychopharmacol Bull 1991; 27: 119-26.
7. Chouinard G, Jones B, Remington G, et al. A Canadian multicenter placebo- controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 1993; 13: 25-40.
8. Fisman S, Steele M. Use of risperidone in pervasive developmental disorders: A case series. J Child Adolesc Psychopharmacol 1996; 6: 177-90.
9. McDougle CJ, Brodkin ES, Yeung PP, et al. Risperidone in adults with autism or pervasive developmental disorder. J Child Adolesc Psychopharmacol 1995; 5: 273-82.
10. Purdon SE, Lit W, Labelle A, et al. Risperidone in the treatment of pervasive developmental disorder. Can J Psychiatry 1994; 39: 400-5.
11. McDougle CJ, Holmes JP, Carlson DC, et al. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry 1998; 55: 633-41.
12. Findling RL, Maxwell K, Wiznicker M. An open clinical trial of risperidone monotherapy in young autistic children. Psychopharmacol Bull 1997; 33: 155-9.
13. McDougle CJ, Holmes JP, Bronson MR, et al. Risperidone treatment of children and adolescents with pervasive developmental disorder: A prospective, open-label study. J Am Acad Child Adolesc Psychiatry, 1997; 36: 685-93.
14. Perry R, Pataki C, Munoz-Silva DM, Armenteros J, Silva RR. Risperidone in children and adolescents with pervasive developmental disorder: Pilot trial and follow-up. J Child Adolesc Psychopharmacol 1997; 7: 167-79.
15. Zuddas A, Di Martino A, Muglia P Cianchetti C. Long-term risperidone for pervasive developmental disorder: efficacy, tolerability and discontinuation. J Child Adolesc Psychopharmacol 2000; 10: 79-90.
16. Schwam JS, Klass E, Alonso C, Perry R. Risperidone and refusal to eat. J Am Acad Child Adolesc Psychiatry 1998; 37: 572-3.
17. Posey DJ, Walsh KH, Wilson GA, McDougle CJ. Risperidone in the treatment of two very young children with autism. J Child Adolesc Psychopharmacol 1999; 9: 273-6.
18. Masi G, Cosenza A, Mucci, M, De Vito G. Risperidone monotherapy in preschool children with young children autistic disorder. J Child Neurol 2001; 16: 395-400.
19. Masi G, Cosenza A, Mucci M, Brovedani P. Open trial of risperidone in 24 young children with pervasive developmental disorder. J Am Acad Child Adolesc Psychiatry 2001; 40: 1206-14.
20. Volkmar FR, Klin A, Marans W, Cohen DJ. The pervasive developmental disorders: diagnosis and assessment. Child Adolesc Psychiatr Clin N Am 1996; 5: 963-78.
21. th ed. Washington DC: American Psychiatric Press, 1994.